Mission

We spare lives by democratizing access to knowledge extracted from real patients journeys.

The Dream

Eliminate hit-or-miss clinical treatment of patients by enabling instant experimentation and simulation of disease progression and treatment outcomes in a computer environment rather than in a clinical setting.

The How

By developing AI that can help humans. Todays options are either human curation of patient data (inefficient and unscalable), or AI (error-prone, needing the help of humans to tune). We are committed to investing in R&D to build an AI that is clinically smart to be of true assistant to different stakeholders in healthcare.

The Story

Mendel is the brain child of Wael Salloum – a computer scientist, and Karim Galil – a physician.

At their first meeting, Karim expressed that his dream as a physician was that every clinical expert mentioned have a “Jarvis” by their side – an AI assistant that could scan all patient records and help them better personalize care for their patients.To his surprise, Wael mentioned that he had been working on a similar AI solution since 2005 – the rest is history.


Out of the Silicon Valley, the world’s center for innovation, they started Mendel.ai and secured funding from some of the world’s best VC firms to re-imagine the future of drug development and clinical practice.

The Name

Mendel is named after the father of genetics, as a tribute to a priest who mastered the skill of “careful observation” to change the field of medicine forever. At Mendel, we have trained our technology to master this very skill.

Health is a human condition, and any technology that doesn’t acknowledge the humanity of healthcare will fail to make its way into the practice of medicine and research. At Mendel, we aim to bring the humanity of our namesake to our technology.

Our board & Advisors

Karim Galil, MD

CEO, Chairman

Wael Salloum, PhD

CTO, Board Director

Kyle Lui

Board Director

Nicolai Wadstrom

Board Director

Mark Goldstein

Advisor

Sam Lambros

Advisor

Ashkon Zariv

Data Integration Engineer

Parth Patel

AI Research Engineer

The People

We train engineers to think like physicians and physicians to think like engineers.

50+

Team Members

2

Offices

1B+

Patient records analyzed

Investors

 

DCM

DCM is a global venture capital firm based in Silicon Valley, Beijing, and Tokyo with over $4 billion under management. DCM has backed industry leading companies including Careem (Uber), Bill.com, Sansan, Freee, Life360, Musical.ly (TikTok), Sling Media. DCM has also invested in exciting, rising startups such as Lime, FuboTV, Hims, Plenty, SoFi, Kuaishou, Maimai and Pony.ai.
 

IndieBio

IndieBio is the life-sciences arm of SOSV which manages over $700 million with a portfolio of over 900 startups. SOSV created the world's first life sciences accelerator in 2014, and in the past five years has backed 200 life science startups, raising more than $700 million, employing over 2,000 people, with a combined valuation of over $3 billion.
 

BootstrapLabs

Founded in 2008, BootstrapLabs is a leading Venture Capital firm based in Silicon Valley and focused on applied artificial intelligence. We invest in founders that dream big and are solving today's hardest problem by applying artificial intelligence to shape a better future. To learn more visit:  https://bootstraplabs.com/
 

LaunchCapital

LaunchCapital invests in great people who re-imagine what’s possible. We back entrepreneurs at the seed and early stages of development and we have invested in over 200 companies including Spotify, Snapchat, and Runkeeper. As part of the Pritzker/Vlock Family Office, LaunchCapital invests across industries and is headquartered in New Haven.  For more information, visit www.launchcapital.com.

What the Experts are Saying

Enterprise validated de-identification

Enterprise validated de-identification

Mendel has validated its clinical AI technology with third party statistical verification.

Mendel is the only company to validate outcomes with AI in a clinical setting

Mendel is the only company to validate outcomes with AI in a clinical setting

Mendel is the only company to validate outcomes with AI in a clinical setting.

UPDATES & NEWS — 2 MIN READ

Deloitte features Mendel in their "Intelligent Trials" Report

Deloitte features Mendel in their "Intelligent Trials" Report

Mendel.ai is improving identification of suitable cancer patients and matching to clinical trials. Mendel.ai, a US-based company founded in 2016, uses AI tools to analyse clinical data, including medical history and genetic analysis, from cancer patients. Its goal is to facilitate clinical trials in oncology research by organising and analysing RWD, and matching patients to the right clinical trials.45 They take medical data from many structured and unstructured data sets and turn these into data digitised patient journeys aligned to specific treatments. Having collected data on over 1 million journeys, its algorithm can segment patient populations by their demographic, such as how African American women with breast cancer respond to a particular drug. In essence creating in silico or patient-less trials. The AI algorithm built on these data helps trial recruitment by finding eligible patients.

The Feed

VIDEO — 8 minutes

Mendel on Hospital-to-Home by UCSF Health Hub

Mendel on Hospital-to-Home by UCSF Health Hub

Mendel's CEO Karim Galil was a guest in Hospital-to-Home by UCSF Health Hub. Karim presented how Mendel transforms EMR data and clinical literature.

Interview — 25 min

Applied AI and Race to 
a COVID-19 Vaccine

Applied AI and Race to 
a COVID-19 Vaccine

Mendel's CEO Karim Galil was a guest in Bootstrap Lab's Applied AI Insiders Series. Karim talked about race to a COVID-19 Vaccine using AI.

UPDATES & NEWS — 2 MIN READ

Mendel releases COVID-19 AI search engine

Mendel releases COVID-19 AI search engine

We’re now excited to announce our new COVID-19 AI search engine which is available to the public here. Mendel ingested and absorbed more than 50,000 scholarly articles, released by the White House, related to Coronaviruses and COVID-19. Researchers, epidemiologists, and clinicians can use this tool to ask questions about COVID-19 and glean relevant answers in seconds — a process that can take a human numerous hours, days, or even weeks to conduct.

UPDATES & NEWS — 2 MIN READ

Silicon Valley Business Journal: San Jose startup flags surprise COVID-19 discovery mined from its new AI platform

Silicon Valley Business Journal: San Jose startup flags surprise COVID-19 discovery mined from its new AI platform

Business Wire: Mendel Launches AI-powered Search Engine to Analyze More Than 50,000 Coronavirus Papers

Business Wire: Mendel Launches AI-powered Search Engine to Analyze More Than 50,000 Coronavirus Papers

Researcher using Mendel’s COVID-19 search engine found evidence that hypertension drug Diltiazem may halt virus replication.

Springer Link: Improving Clinical Trial Participant Prescreening With Mendel Artificial Intelligence (AI)

Springer Link: Improving Clinical Trial Participant Prescreening With Mendel Artificial Intelligence (AI)

A Comparison of the Results of AI-Assisted vs Standard Methods in 3 Oncology Trials